ALTEVAX
-
Batoul FARHAT - Head of business development
-
Michael Heim - CFO
- Adresse 55 avenue Marceau, 75116 Paris - France
- Catégorie PME, ETI, TPE
- Secteur Domaine des biotechnologies (biotech)
- Site web
Présentation de l’entreprise
ALTEVAX is a preclinical biotech firm creating a groundbreaking immunotherapy platform using synthetic Melanin and versatile peptides for cancer treatment. With proven efficacy in animal trials and strong patent protection, our lead vaccine against Glioblastoma is nearing Clinical Trial Phase 1/2a.